Rocket


News + Filings
Transactions
Holdings



Cormorant Asset Management, LP

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
03/16/2023Ambrx Biopharma Inc. PurchaseOrdinary Shares500k$10.15$5.1MSee Footnotes03/14/2023
03/15/2023Ambrx Biopharma Inc. PurchaseOrdinary Shares250k$10.60$2.6MSee Footnotes03/14/2023
03/14/2023Ambrx Biopharma Inc. PurchaseOrdinary Shares250k$9.95$2.5MSee Footnotes03/14/2023
01/11/2022Vigil Neuroscience, Inc. ConversionCommon Stock616.8k$0.00$0See Footnotes01/11/2022
01/11/2022Vigil Neuroscience, Inc. ConversionSeries B Convertible Preferred Stock616.8k$0.00$0See Footnotes01/11/2022
10/25/2021Ventyx Biosciences, Inc. ConversionCommon Stock785.3k$0.00$0See Footnotes10/25/2021
10/25/2021Ventyx Biosciences, Inc. PurchaseCommon Stock625k$16.00$10MSee Footnotes10/25/2021
10/25/2021Ventyx Biosciences, Inc. ConversionSeries A Convertible Preferred Stock548.3k$0.00$0See Footnotes10/25/2021
10/25/2021Ventyx Biosciences, Inc. ConversionSeries B Convertible Preferred Stock237k$0.00$0See Footnotes10/25/2021
10/13/2021Pyxis Oncology, Inc.PYXSConversionSeries B Convertible Preferred Stock668.9k$0.00$0See Footnotes10/13/2021
10/13/2021Pyxis Oncology, Inc.PYXSConversionCommon Stock668.9k$0.00$0See Footnotes10/13/2021
10/13/2021Pyxis Oncology, Inc.PYXSPurchaseCommon Stock450k$16.00$7.2MSee Footnotes10/13/2021
08/02/2021Icosavax, Inc.ICVXConversionCommon Stock426.4k$0.00$0See Footnotes08/02/2021
08/02/2021Icosavax, Inc.ICVXConversionSeries B-1 Convertible Preferred Stock426.4k$0.00$0See Footnotes08/02/2021
07/02/2021Aerovate Therapeutics, Inc.AVTEConversionCommon Stock1.5M$0.00$0See Footnotes07/02/2021
07/02/2021Aerovate Therapeutics, Inc.AVTEPurchaseCommon Stock500k$14.00$7MSee Footnotes07/02/2021
07/02/2021Aerovate Therapeutics, Inc.AVTEConversionSeries A Convertible Preferred Stock1.5M$0.00$0See Footnotes07/02/2021
06/29/2021Elevation Oncology, Inc.ELEVConversionCommon Stock2M$0.00$0See Footnotes06/29/2021
06/29/2021Elevation Oncology, Inc.ELEVPurchaseCommon Stock250k$16.00$4MSee Footnotes06/29/2021
06/29/2021Elevation Oncology, Inc.ELEVConversionSeries B Convertible Preferred Stock2M$0.00$0See Footnotes06/29/2021
06/21/2021Verve Therapeutics, Inc. ConversionCommon Stock709.2k$0.00$0See Footnotes06/21/2021
06/21/2021Verve Therapeutics, Inc. PurchaseCommon Stock275k$19.00$5.2MSee Footnotes06/21/2021
06/21/2021Verve Therapeutics, Inc. ConversionSeries B Convertible Preferred Stock709.2k$0.00$0See Footnotes06/21/2021
04/15/2021Biomea Fusion, Inc. GrantStock Option (right to buy)28.9k$17.00$491.5k 04/15/2021
03/30/2021Design Therapeutics, Inc.DSGNConversionCommon Stock4.4M$0.00$0See Footnotes03/30/2021
03/30/2021Design Therapeutics, Inc.DSGNPurchaseCommon Stock750k$20.00$15MSee Footnotes03/30/2021
03/30/2021Design Therapeutics, Inc.DSGNConversionSeries A Convertible Preferred Stock3M$0.00$0See Footnotes03/30/2021
03/30/2021Design Therapeutics, Inc.DSGNConversionSeries B Convertible Preferred Stock1.4M$0.00$0See Footnotes03/30/2021
03/16/2021Prometheus Biosciences, Inc.RXDXConversionCommon Stock1.8M$0.00$0See Footnotes03/16/2021
03/16/2021Prometheus Biosciences, Inc.RXDXPurchaseCommon Stock375k$19.00$7.1MSee Footnotes03/16/2021
03/16/2021Prometheus Biosciences, Inc.RXDXConversionSeries D-1 Convertible Preferred Stock763.3k$0.00$0See Footnotes03/16/2021
03/16/2021Prometheus Biosciences, Inc.RXDXConversionSeries D-2 Convertible Preferred Stock1.1M$0.00$0See Footnotes03/16/2021
12/18/2020BioAtla, Inc. ConversionCommon Stock1.5M$0.00$0See Footnotes12/18/2020
12/18/2020BioAtla, Inc. PurchaseCommon Stock800k$18.00$14.4MSee Footnotes12/18/2020
12/18/2020BioAtla, Inc. ConversionSeries D Convertible Preferred Stock1.5M$0.00$0See Footnotes12/18/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy